Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

10x Genomics (TXG) R&D In Process (2018 - 2020)

Historic R&D In Process for 10x Genomics (TXG) over the last 2 years, with Q4 2020 value amounting to $406.9 million.

  • 10x Genomics' R&D In Process changed N/A to $406.9 million in Q4 2020 from the same period last year, while for Dec 2021 it was $447.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $447.5 million for FY2020, which is N/A changed from last year.
  • 10x Genomics' R&D In Process amounted to $406.9 million in Q4 2020.
  • 10x Genomics' 5-year R&D In Process high stood at $406.9 million for Q4 2020, and its period low was $16.1 million during Q3 2018.